Research Paper Volume 14, Issue 21 pp 8700—8718
Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer
Figure 9. Tumor immune sensitive drug prediction. (A) Top 200 up- and downregulated significantly expressed genes between the high- and low-risk groups. (B, C) GO and KEGG enrichment analyses of differentially expressed genes. (D) Pie chart of tumor immune-sensitive drug types.